Truist знижує цільову ціну CHCT, зберігаючи позитивний прогноз зростання

What happened: On March 10, Truist Securities lowered its price target on Community Healthcare Trust Incorporated (NYSE:CHCT) to $19 from $20, while maintaining a 'Buy' rating. This followed a strategic realignment by CHCT, involving a reduction in its quarterly dividend to retain approximately $25 million.

Market impact: The healthcare real estate sector was affected, with investors reassessing CHCT's valuation following the dividend cut. Truist's price target reduction reflects this repricing. Despite the cut, Truist's 'Buy' rating signals confidence in CHCT's long-term growth prospects.

What to watch next: CHCT's Q2 2026 earnings call on May 15 will provide insights into the company's operational drivers and strategic realignment. Additionally, investors will monitor Truist's future ratings and price targets for CHCT and other healthcare REITs to gauge the sector's sentiment.